A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Stemline Therapeutics, Inc.
InSightec
Hoffmann-La Roche
AstraZeneca
Sapience Therapeutics
Adela, Inc
AstraZeneca
Beijing Biostar Pharmaceuticals Co., Ltd.
Novartis
AVM Biotechnology Inc
Biogen
Tempus AI
Taproot Health
VitaMed Research LLC
Seagen Inc.
Hoffmann-La Roche
Shanghai Yunying Medical Technology
Angiochem Inc
Quadriga Biosciences, Inc.
Health Clinics Limited
US Oncology Research
Eli Lilly and Company
SpeciCare
DEKK-TEC, Inc.
Celgene
Angiochem Inc
Seagen Inc.
Novartis
IGF Oncology, LLC
Novartis
Merck Sharp & Dohme LLC
Novartis
Angiochem Inc
Sanofi
GlaxoSmithKline
BBB-Therapeutics B.V.
Angiochem Inc
GlaxoSmithKline
Pharmacyclics LLC.
INSYS Therapeutics Inc
Spectrum Pharmaceuticals, Inc
Novartis